End-procedural complete haemodynamic response may not be essential for the clinical success of TIPS in patients with cirrhosis
D. Roccarina,M. Rosi,D. Saltini,V. Adotti,M. Senzolo,S. Nardelli,T. Guasconi,S. Gitto,L. Biribin,S. Gioia,F. Indulti,C. Campani,P. Burra,O. Riggio,F. Marra,F. Schepis,F. Vizzutti
DOI: https://doi.org/10.1016/j.dld.2024.01.008
IF: 5.165
2024-02-01
Digestive and Liver Disease
Abstract:Background Transjugular intrahepatic portosystemic shunt (TIPS) is a well-established treatment for variceal bleeding (VB) and refractory ascites (RA) in cirrhosis. Immediate post-TIPS complete haemodynamic response (CHR), defined as a post-TIPS porto-caval gradient (PCG) <12 mmHg in VB and RA, or 50% PCG reduction in VB, is used to define a treatment success. TIPS underdilation reduces post-derivative complications, although with this strategy CHR is not always achieved, raising concerns on control of portal hypertensive complications and survival. Aim We compared ascites control, bleeding recurrence and mortality rate among patients achieving CHR or partial haemodynamic response (PHR) after TIPS. Methods We retrospectively analysed a series of cirrhotic patients who consecutively received TIPS for RA or secondary prophylaxis of VB at four referral Italian Centers from 2007 to 2021. Results 415 patients, median age 61(15), 28% females were enrolled. TIPS was indicated in 51% for VB and in 49% for RA. Fifty-percent received underdilated TIPS (<8mm). Overall, a CHR was achieved in 65%, with a median post-TIPS PCG/% of PGC reduction of 8(4) mmHg/60(19)%. In PHR, post-TIPS PCG/% of PGC reduction was 15(4) mmHg/36(14)%. Non-significant differences were observed in rebleeding rate (5% vs 4%, p=0.73, in CHR vs PHR, respectively) (Fig.1A). The grade of ascites or the need for large volume paracentesis at 3, 6, 12 months did not significantly differ (p=0.76, 0.77, 0.86, respectively) between CHR and PHR (Fig.1B). The median overall survival was 24(34) months. Regardless of TIPS indication, survival was not significant different between CHR and PHR (Fig.2). Advanced age, disease severity before TIPS and eventual development of HCC resulted as predictors of mortality. Conclusions CHR immediately after TIPS may not be essential to define the clinical success, with a substantial reduction in PCG exerting a pivotal role. Further studies are needed to identify a minimal threshold for PCG reduction.
gastroenterology & hepatology